The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

The Justice Department on Monday released special counsel David Weiss' final report on his investigation into Hunter Biden.

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and ...

Trump administrations pro-corporation policies boost healthcare M&A prospects Healthcare investment outlook improves as Trump ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...

Sonova Holding AG / Key word (s): Conference Sonova to present at the J.P. Morgan 2025 Healthcare Conference 13.01.2025 / 18:00 CET/CEST ...